| Domain | Rank | Visitors | Earning per month | Valuation |
| fiercepharma.com | 57500 | 22,671 | 2,952$ | 88560$ |
| roche.com | 32543 | 11,709 | 3,811$ | 114330$ |
| abbvie.com | 60798 | 12,326 | 2,866$ | 85980$ |
| sanofi.com | 81025 | 6,180 | 1,207$ | 36210$ |
| merck.com | 43431 | 11,263 | 2,723$ | 81690$ |
| biospace.com | 52236 | 8,927 | 2,491$ | 74730$ |
| pharmaceutical-technology.com | 180506 | 14,910 | 1,664$ | 49920$ |
| endpts.com | 115404 | 9,795 | 1,640$ | 49200$ |
| Moz Backlinks Count | 3640 |
| Moz Page Rank | 5 |
| Domain Authority (DA) | 73.0 |
| Page Authority (PA) | 54.0 |
| Country | Rank | Pct |
|---|
| Country Name | United States |
| Country Rank | 40179
5745
|
| Daily unique visits | 16,616 |
| Daily Page Views | 31,570 |
| Income Per Day | 2,936 USD |
| Novartis.com valuation | 88080 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | My Cancer. My Words. |
| No | Text |
| 1 | Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH) |
| Social | Count |
| Facebook Likes | 15543 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |